Literature DB >> 7045531

Specific tumor immunity produced by the injection of vaccinia viral oncolysates.

M K Wallack.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7045531     DOI： 10.1016/0022-4804(82)90003-8

Source DB:  PubMed          Journal:  J Surg Res        ISSN： 0022-4804            Impact factor:   2.192


× No keyword cloud information.
  3 in total

1.  Active specific immunotherapy of pulmonary metastasis with vaccinia melanoma oncolysate prepared from granulocyte/macrophage-colony-stimulating-factor-gene-encoded vaccinia virus.

Authors:  D W Ju; X Cao; B Acres
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

2.  Favorable clinical responses in subsets of patients from a randomized, multi-institutional melanoma vaccine trial.

Authors:  M K Wallack; M Sivanandham; B Whooley; K Ditaranto; A A Bartolucci
Journal:  Ann Surg Oncol       Date:  1996-03       Impact factor: 5.344

3.  Therapeutic effect of a vaccinia colon oncolysate prepared with interleukin-2-gene encoded vaccinia virus studied in a syngeneic CC-36 murine colon hepatic metastasis model.

Authors:  M Sivanandham; S D Scoggin; N Tanaka; M K Wallack
Journal:  Cancer Immunol Immunother       Date:  1994-04       Impact factor: 6.968
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.